180 related articles for article (PubMed ID: 15456475)
41. Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
van Geffen M; Mathijssen NC; Holme PA; Laros-van Gorkom BA; van Kraaij MG; Masereeuw R; Peyvandi F; van Heerde WL
Thromb Res; 2013 Jul; 132(1):116-22. PubMed ID: 23731565
[TBL] [Abstract][Full Text] [Related]
42. The spectrum of factor VII deficiencies and abnormalities.
Girolami A
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):283-4; author reply 284. PubMed ID: 15060429
[No Abstract] [Full Text] [Related]
43. Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
Michaels LA; Philipp CS; Eisele J; Pappas H; Saidi P
Pediatr Blood Cancer; 2007 Oct; 49(5):736-9. PubMed ID: 16317734
[TBL] [Abstract][Full Text] [Related]
44. rFVIIa (Novoseven): the new panacea?
Ickx BE
Acta Anaesthesiol Belg; 2003; 54(4):333-5. PubMed ID: 14719355
[No Abstract] [Full Text] [Related]
45. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
[No Abstract] [Full Text] [Related]
46. Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency.
O'Rourke N; Lee C; Kodali BS; Harnett M
Can J Anaesth; 2006 May; 53(5):528-9. PubMed ID: 16636044
[No Abstract] [Full Text] [Related]
47. Experiences with recombinant factor VIIa in haemophiliacs.
Hedner U
Curr Stud Hematol Blood Transfus; 1991; (58):63-8. PubMed ID: 1954776
[No Abstract] [Full Text] [Related]
48. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Manning BJ; Hynes N; Courtney DF; Sultan S
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
[TBL] [Abstract][Full Text] [Related]
49. Trial of haemophilia treatment for intracerebral haemorrhage.
Lowe R
Lancet Neurol; 2004 Aug; 3(8):448. PubMed ID: 15303268
[No Abstract] [Full Text] [Related]
50. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
Beckman JD; Holle LA; Wolberg AS
J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
[TBL] [Abstract][Full Text] [Related]
51. Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Ng HJ; Lee LH
Ann Acad Med Singap; 2002 Mar; 31(2):241-4. PubMed ID: 11957567
[TBL] [Abstract][Full Text] [Related]
52. Recombinant activated factor VII in clinical practice: a 2014 update.
Franchini M; Crestani S; Frattini F; Sissa C; Bonfanti C
J Thromb Thrombolysis; 2015 Feb; 39(2):235-40. PubMed ID: 25015059
[TBL] [Abstract][Full Text] [Related]
53. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis.
Shima M
Semin Hematol; 2004 Jan; 41(1 Suppl 1):125-31. PubMed ID: 14872433
[TBL] [Abstract][Full Text] [Related]
54. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Baudo F; de Cataldo F; Gaidano G;
Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
[TBL] [Abstract][Full Text] [Related]
55. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
[No Abstract] [Full Text] [Related]
56. Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.
Hedner U; Brun NC
Neuroradiology; 2007 Oct; 49(10):789-93. PubMed ID: 17653706
[TBL] [Abstract][Full Text] [Related]
57. Potential role for rFVIIa in transfusion medicine.
Hedner U; Erhardtsen E
Transfusion; 2002 Jan; 42(1):114-24. PubMed ID: 11896322
[No Abstract] [Full Text] [Related]
58. In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
Augustsson C; Persson E
Blood; 2014 Nov; 124(20):3172-4. PubMed ID: 25232061
[TBL] [Abstract][Full Text] [Related]
59. On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
Tarantino M; Aledort L
Transfusion; 2001 Dec; 41(12):1628-9. PubMed ID: 11778084
[No Abstract] [Full Text] [Related]
60. Successful use of recombinant activated factor VII administered via automated bolus pump following emergency laparoscopic appendectomy in a patient with mild congenital FVII deficiency: Case report.
Perkins H; Klaassen RJ
Pediatr Blood Cancer; 2021 Aug; 68(8):e28974. PubMed ID: 33629793
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
